Rona Therapeutics Raises $35 Million Series A+ Financing to Advance Innovative Metabolic siRNA Pipeline in Clinic and Next Generation RNA Platforms
Published on 08/07/2025 at 18:06 | prnewswire.co.uk
Financing led by LongRiver Investments with participation by new and existing global investment fundsRona will use proceeds to progress leading metabolic siRNA pipeline programs into global development and expand extra-hepatic delivery platform in CNS and beyondor contact: BD@ronatherapeutics.com
View original content:
en | boerse | 67957939 |
